# EDGAR Filing Document

**Accession Number:** 0001501570
**File Stem:** 0001501570-25-000129
**Filing Date:** 2025-7
**Character Count:** 8249
**Document Hash:** a270e66eafbb048d2f5a6bc7b85f25e3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001501570-25-000129.hdr.sgml**: 20250724

**ACCESSION NUMBER**: 0001501570-25-000129

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250722

**FILED AS OF DATE**: 20250724

**DATE AS OF CHANGE**: 20250724

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Renfro LaVonda
- **CENTRAL INDEX KEY:** 0001621578

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36682
- **FILM NUMBER:** 251148179

**BUSINESS ADDRESS:**
- **BUSINESS PHONE:** 972-349-6150

**MAIL ADDRESS:**
- **STREET 1:** 8214 WESTCHESTER DRIVE, SUITE 400
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75225
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Veritex Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001501570
- **STANDARD INDUSTRIAL CLASSIFICATION:** STATE COMMERCIAL BANKS [6022]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 270973566
- **STATE OF INCORPORATION:** TX
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 8214 WESTCHESTER DRIVE
- **STREET 2:** SUITE 800
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75225
- **BUSINESS PHONE:** 972-349-6200

**MAIL ADDRESS:**
- **STREET 1:** 8214 WESTCHESTER DRIVE
- **STREET 2:** SUITE 800
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75225

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Renfro LaVonda<br><sub>(Last) (First) (Middle)</sub><br>C/O VERITEX HOLDINGS, INC.<br>8214 WESTCHESTER DRIVE, SUITE 800<br><sub>(Street)</sub><br>DALLAS, TX 75225<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-07-22 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Operating Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Veritex Holdings, Inc. [ VBTX ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-07-22 |  | M |  | 4114 | A | $16.21 | 64323 | D |  |
| Common Stock | 2025-07-22 |  | S |  | 4114 | D | $32.4501 | 60209 | D |  |
| Common Stock | 2025-07-22 |  | M |  | 3500 | A | $26.71 | 63709 | D |  |
| Common Stock | 2025-07-22 |  | S |  | 3500 | D | 32.3898<sup>(1)</sup> | 60209 | D |  |
| Common Stock | 2025-07-22 |  | M |  | 4727 | A | $27.59 | 64936 | D |  |
| Common Stock | 2025-07-22 |  | S |  | 4727 | D | 32.3811<sup>(2)</sup> | 60209 | D |  |
| Common Stock | 2025-07-22 |  | M |  | 7902 | A | $21.38 | 68111 | D |  |
| Common Stock | 2025-07-22 |  | S |  | 7902 | D | $32.38 | 60209 | D |  |
| Common Stock | 2025-07-22 |  | M |  | 20000 | A | $21.38 | 80209 | D |  |
| Common Stock | 2025-07-22 |  | S |  | 20000 | D | 32.3649<sup>(3)</sup> | 60209 | D |  |
| Common Stock | 2025-07-22 |  | M |  | 13168 | A | $29.13 | 73377 | D |  |
| Common Stock | 2025-07-22 |  | S |  | 13168 | D | 32.3679<sup>(4)</sup> | 60209 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Employee Stock Option (right to buy) | $16.21 | 2025-07-22 |  | M |  |  | 4114 | <sup>(5)</sup> | 2026-01-01 | Common Stock | 4114 | $16.21 | 0 | D |  |
| Employee Stock Option (right to buy) | $26.71 | 2025-07-22 |  | M |  |  | 3500 | <sup>(5)</sup> | 2027-01-01 | Common Stock | 3500 | $26.71 | 0 | D |  |
| Employee Stock Option (right to buy) | $27.59 | 2025-07-22 |  | M |  |  | 4727 | <sup>(6)</sup> | 2028-01-01 | Common Stock | 4727 | $27.59 | 0 | D |  |
| Employee Stock Option (right to buy) | $21.38 | 2025-07-22 |  | M |  |  | 7902 | <sup>(5)</sup> | 2029-01-01 | Common Stock | 7902 | $21.38 | 0 | D |  |
| Employee Stock Option (right to buy) | $21.38 | 2025-07-22 |  | M |  |  | 20000 | <sup>(5)</sup> | 2029-01-01 | Common Stock | 20000 | $21.38 | 0 | D |  |
| Employee Stock Option (right to buy) | $29.13 | 2025-07-22 |  | M |  |  | 13168 | <sup>(5)</sup> | 2030-01-01 | Common Stock | 13168 | $29.13 | 0 | D |  |

---

### Footnotes:

(1) Reflects the weighted average sales price for the reported transactions. The shares were sold in multiple transactions at prices ranging from $32.385 to $32.3912, inclusive.

(2) Reflects the weighted average sales price for the reported transactions. The shares were sold in multiple transactions at prices ranging from $32.37 to $32.387, inclusive.

(3) Reflects the weighted average sales price for the reported transactions. The shares were sold in multiple transactions at prices ranging from $32.36 to $32.39, inclusive.

(4) Reflects the weighted average sales price for the reported transactions. The shares were sold in multiple transactions at prices ranging from $32.36 to $32.40, inclusive.

(5) Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche.

(6) Grant vest on January 1, 2019.

**Signature:** /s/ C. Malcolm Holland, III, by power of attorney  
**Date:** 2025-07-24

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**